Polomar Health Services Quick Ratio (PMHS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Polomar Health Services, Inc.  (OTC: PMHS)

Polomar Health Services's Quick Ratio

PMHS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Polomar Health Services's Cash & cash equivalent grew by 94.08 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Polomar Health Services's Quick Ratio to 0.18, Quick Ratio remained below Polomar Health Services, Inc. average.

Within Major Pharmaceutical Preparations industry Polomar Health Services, Inc. booked the highest Quick Ratio than Polomar Health Services in the second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 12, from total ranking in the first quarter 2026 at 13.

Explain Quick Ratio?
How much Cash & cash equivalents PMHS´s has?
What are PMHS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PMHS Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 185.73 % 190.39 % 316.62 % 459.78 % 1532.02 %
Y / Y Cash & cash equivalent Change 1271.33 % -30.01 % 828.29 % 90.08 % 4466.67 %
Quick Ratio MRQ 0.18 0.1 0.21 0.07 0.04
PMHS's Total Ranking # 12 # 13 # # #
Seq. Current Liabilities Change 15.03 % 34.54 % 2.19 % 80.68 % 16.9 %
Seq. Cash & cash equivalent Change 94.08 % -31.4 % 194.57 % 249.64 % -90.09 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 0
Healthcare Sector # 0
Overall Market # 12


Quick Ratio Statistics
High Average Low
3.02 0.62 0
(Dec 31 2023)   (Mar 31 2024)




Financial Statements
Polomar Health Services's Current Liabilities $ 1 Millions Visit PMHS's Balance sheet
Polomar Health Services's Cash & cash equivalent $ 0 Millions Visit PMHS's Balance sheet
Source of PMHS's Sales Visit PMHS's Sales by Geography


Cumulative Polomar Health Services's Quick Ratio

PMHS's Quick Ratio for the trailling 12 Months

PMHS Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 243.12 % 324.17 % 424.76 % 408.52 % 399.69 %
Y / Y Cash & cash equivalent TTM Growth 146.19 % 67.32 % 733.74 % -14.41 % -14.9 %
Quick Ratio TTM 0.14 0.11 0.17 0.14 0.2
Total Ranking TTM # 3596 # 4128 # 3299 # 3350 # 3353
Seq. Current Liabilities TTM Growth 26.02 % 29.57 % 34.18 % 56.61 % 55.79 %
Seq. Cash & cash equivalent TTM Growth 58.15 % -12.17 % 58.53 % 11.8 % 7.49 %

Quick ratio ranking by company, industry and sector >> Back to PMHS Financial Strength Comparisons >> Go to Compare PMHS Quick Ratio to its Competitors

On the trailing twelve months basis PMHS Cash & cash equivalent more than doubled by 1271.33 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Polomar Health Services's Quick Ratio to 0.14, Quick Ratio remained below PMHS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry PMHS achieved the highest Quick Ratio. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 17.

Explain Quick Ratio?
How much Cash & cash equivalents PMHS´s has?
What are PMHS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market # 12


trailing twelve months Quick Ratio Statistics
High Average Low
2.53 0.46 0.02
(Dec 31 2023)  




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Aytu Biopharma Inc  0.48 $ 26.308  Millions$ 54.659  Millions
Jupiter Neurosciences Inc   0.47 $ 1.522  Millions$ 3.251  Millions
Aeon Biopharma inc   0.47 $ 3.431  Millions$ 7.342  Millions
Evolus Inc   0.46 $ 45.170  Millions$ 98.731  Millions
Biomarin Pharmaceutical Inc  0.45 $ 874.005  Millions$ 1,927.164  Millions
Pds Biotechnology Corp  0.45 $ 5.596  Millions$ 12.377  Millions
Biofrontera Inc   0.44 $ 4.659  Millions$ 10.541  Millions
Beyondspring Inc   0.43 $ 10.361  Millions$ 23.834  Millions
Organon and Co   0.43 $ 1,132.000  Millions$ 2,616.000  Millions
Gossamer Bio Inc   0.41 $ 57.026  Millions$ 137.783  Millions
Bausch Health Companies Inc   0.39 $ 1,825.000  Millions$ 4,687.000  Millions
Johnson and Johnson  0.38 $ 21,094.000  Millions$ 54,895.000  Millions
Ultragenyx Pharmaceutical Inc   0.36 $ 125.000  Millions$ 351.000  Millions
Vanda Pharmaceuticals Inc   0.34 $ 56.119  Millions$ 164.026  Millions
Ainos Inc   0.29 $ 1.423  Millions$ 4.928  Millions
Elanco Animal Health Incorporated  0.29 $ 530.000  Millions$ 1,852.000  Millions
Provectus Biopharmaceuticals Inc   0.27 $ 1.157  Millions$ 4.234  Millions
Vireo Growth Inc.  0.27 $ 104.100  Millions$ 390.700  Millions
Phibro Animal Health Corporation  0.26 $ 81.994  Millions$ 316.468  Millions
Merck and Co Inc   0.26 $ 7,141.000  Millions$ 27,731.000  Millions
Indivior Pharmaceuticals Inc   0.26 $ 222.000  Millions$ 868.000  Millions
Propanc Biopharma Inc   0.25 $ 0.832  Millions$ 3.354  Millions
Teva Pharmaceutical Industries Limited  0.23 $ 3,655.000  Millions$ 15,646.000  Millions
Cytodyn inc   0.22 $ 11.852  Millions$ 53.727  Millions
Collegium Pharmaceutical Inc   0.22 $ 129.467  Millions$ 589.861  Millions
International Stem Cell Corporation  0.22 $ 1.089  Millions$ 4.984  Millions
Earth Science Tech Inc   0.22 $ 0.631  Millions$ 2.902  Millions
Viatris Inc   0.22 $ 1,368.700  Millions$ 6,345.800  Millions
Eli Lilly And Company  0.19 $ 8,950.000  Millions$ 47,741.000  Millions
Polomar Health Services, Inc.  0.18 $ 0.188  Millions$ 1.063  Millions

Date modified: 2026-09-26T07:44:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.